JP5483846B2 - 鳥類ムネ肉から得られる機能性素材及びその製造方法 - Google Patents
鳥類ムネ肉から得られる機能性素材及びその製造方法 Download PDFInfo
- Publication number
- JP5483846B2 JP5483846B2 JP2008232555A JP2008232555A JP5483846B2 JP 5483846 B2 JP5483846 B2 JP 5483846B2 JP 2008232555 A JP2008232555 A JP 2008232555A JP 2008232555 A JP2008232555 A JP 2008232555A JP 5483846 B2 JP5483846 B2 JP 5483846B2
- Authority
- JP
- Japan
- Prior art keywords
- functional material
- extract
- plasmalogen
- fillet
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000463 material Substances 0.000 title claims description 54
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 58
- 239000000284 extract Substances 0.000 claims description 47
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 32
- 238000000605 extraction Methods 0.000 claims description 27
- 235000013372 meat Nutrition 0.000 claims description 26
- 150000003904 phospholipids Chemical class 0.000 claims description 26
- 150000001413 amino acids Chemical class 0.000 claims description 19
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 19
- 108010085443 Anserine Proteins 0.000 claims description 16
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 16
- 108010087806 Carnosine Proteins 0.000 claims description 16
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 claims description 16
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 16
- 241000210053 Potentilla elegans Species 0.000 claims description 16
- 229930003427 Vitamin E Natural products 0.000 claims description 16
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 claims description 16
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 16
- 229940044199 carnosine Drugs 0.000 claims description 16
- 235000019165 vitamin E Nutrition 0.000 claims description 16
- 239000011709 vitamin E Substances 0.000 claims description 16
- 229940046009 vitamin E Drugs 0.000 claims description 16
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 14
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 13
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 12
- 229940110767 coenzyme Q10 Drugs 0.000 claims description 12
- 239000000469 ethanolic extract Substances 0.000 claims description 11
- 229960004203 carnitine Drugs 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 235000013373 food additive Nutrition 0.000 claims description 5
- 239000002778 food additive Substances 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 239000000490 cosmetic additive Substances 0.000 claims description 4
- 238000002481 ethanol extraction Methods 0.000 claims description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims 2
- 235000013305 food Nutrition 0.000 description 22
- 229940067631 phospholipid Drugs 0.000 description 22
- 229940024606 amino acid Drugs 0.000 description 17
- 235000001014 amino acid Nutrition 0.000 description 17
- 241000271566 Aves Species 0.000 description 14
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 12
- 206010034203 Pectus Carinatum Diseases 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 10
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 9
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 8
- 241000287828 Gallus gallus Species 0.000 description 8
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 8
- 235000013330 chicken meat Nutrition 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 206010012438 Dermatitis atopic Diseases 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 201000008937 atopic dermatitis Diseases 0.000 description 4
- 150000005693 branched-chain amino acids Chemical class 0.000 description 4
- 229960001231 choline Drugs 0.000 description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000037356 lipid metabolism Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229940087168 alpha tocopherol Drugs 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000010382 gamma-tocopherol Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 229960000310 isoleucine Drugs 0.000 description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- 235000004835 α-tocopherol Nutrition 0.000 description 3
- 239000002478 γ-tocopherol Substances 0.000 description 3
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000008204 material by function Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000287127 Passeridae Species 0.000 description 1
- JCABVIFDXFFRMT-DIPNUNPCSA-N [(2r)-1-[ethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] octadec-9-enoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC)OC(=O)CCCCCCCC=CCCCCCCCC JCABVIFDXFFRMT-DIPNUNPCSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- ADFCQWZHKCXPAJ-GFCCVEGCSA-N equol Chemical compound C1=CC(O)=CC=C1[C@@H]1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-GFCCVEGCSA-N 0.000 description 1
- 235000019126 equol Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- ADFCQWZHKCXPAJ-UHFFFAOYSA-N indofine Natural products C1=CC(O)=CC=C1C1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
項1. 鳥類ムネ肉に対してアルコール抽出処理を行うことにより得られる抽出物を含むことを特徴とする、機能性素材。
項2. 前記アルコール抽出処理が、エタノール抽出処理である、項1に記載の機能性素材。
項3. 鳥類が鶏である、項1又は2に記載の機能性素材。
項4. 食品添加剤である、項1乃至3のいずれかに記載の機能性素材。
項5. 化粧料用添加剤である、項1乃至3のいずれかに記載の機能性素材。
項6. 医薬用添加剤である、項1乃至3のいずれかに記載の機能性素材。
項7. 鳥類ムネ肉に対してアルコールを抽出溶媒として抽出処理し、抽出液を回収する工程を含む、機能性素材の製造方法。
項8. 前記アルコールが、エタノールである、項7に記載の製造方法。
項9. 前記鳥類ムネ肉が、乾燥処理されてなるものである、項7又は8に記載の製造方法。
これらの中でも、鶏は、飼育数も多く安価に入手でき、しかもプラズマローゲン型リン脂質、アンセリン、カルノシン、アミノ酸、ビタミンE、カルニチン、コエンザイムQ10等の有用成分が比較的多く含まれるため、好適に使用される。鶏の中でも、とりわけレイヤー(特に採卵終了後のレイヤー)のムネ肉は、有効な利用価値が従来見出されていなかったが、本発明によればレイヤーのムネ肉からも有用成分が効率的に抽出された機能性素材が提供される。このようなレイヤーのムネ肉の有効利用という観点から、本発明において、使用される鳥類ムネ肉としてレイヤー由来のムネ肉が好適である。
実施例1
レイヤーのムネ肉を8mmサイズにミンチ化したものを凍結乾燥し、更にフレーカーにて2〜5mm程度に細切した。斯くして処理されたムネ肉300gに対して、エタノール1000mLを添加し、37℃で約12時間攪拌を行って抽出処理を実施した。次いで、濾過にて固液分離を行い、抽出液(以下、抽出液1と表記する)を回収した。分離された残渣に対して、再度エタノール1000mLを添加し、上記と同条件で抽出処理を実施した後に、濾過にて固液分離を行い、抽出液(以下、抽出液2と表記する)を回収した。
Claims (7)
- レイヤーのムネ肉に対してエタノール抽出処理を行うことにより得られる抽出物であって、
1g(乾燥重量換算)当たり、プラズマローゲン型リン脂質5〜50mg、非プラズマローゲン型リン脂質8〜70mg、アンセリン0.3〜3mg、カルノシン0.05〜0.5mg、アミノ酸0.2〜2mg、ビタミンE0.1〜1mg、カルニチン0.25〜2.5mg、コエンザイムQ10 0.1〜1mgが含まれる、エタノール抽出物
を含むことを特徴とする、機能性素材。 - 食品添加剤である、請求項1に記載の機能性素材。
- 化粧料用添加剤である、請求項1に記載の機能性素材。
- 医薬用添加剤である、請求項1に記載の機能性素材。
- レイヤーのムネ肉に対してエタノールを抽出溶媒として抽出処理し、抽出液を回収する工程を含む、
1g(乾燥重量換算)当たり、プラズマローゲン型リン脂質5〜50mg、非プラズマローゲン型リン脂質8〜70mg、アンセリン0.3〜3mg、カルノシン0.05〜0.5mg、アミノ酸0.2〜2mg、ビタミンE0.1〜1mg、カルニチン0.25〜2.5mg、コエンザイムQ10 0.1〜1mgが含まれる、エタノール抽出物を含む機能性素材の製造方法。 - 前記レイヤーのムネ肉が、乾燥処理されてなるものである、請求項5に記載の製造方法。
- 機能性素材が、食品添加剤、化粧料用添加剤又は医薬用添加剤である、請求項5又は6に記載の製造方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008232555A JP5483846B2 (ja) | 2008-09-10 | 2008-09-10 | 鳥類ムネ肉から得られる機能性素材及びその製造方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008232555A JP5483846B2 (ja) | 2008-09-10 | 2008-09-10 | 鳥類ムネ肉から得られる機能性素材及びその製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010063406A JP2010063406A (ja) | 2010-03-25 |
JP5483846B2 true JP5483846B2 (ja) | 2014-05-07 |
Family
ID=42189575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008232555A Active JP5483846B2 (ja) | 2008-09-10 | 2008-09-10 | 鳥類ムネ肉から得られる機能性素材及びその製造方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5483846B2 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019208392A1 (ja) | 2018-04-27 | 2019-10-31 | 株式会社レオロジー機能食品研究所 | 新規プラズマローゲン誘導体 |
WO2020213132A1 (ja) | 2019-04-18 | 2020-10-22 | 株式会社レオロジー機能食品研究所 | プラズマローゲンを含む機能性素材の製造方法 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6167267B2 (ja) * | 2015-09-18 | 2017-07-26 | 株式会社保健科学研究所 | 皮膚や大腸粘膜の改善剤 |
JP6603923B2 (ja) * | 2016-05-02 | 2019-11-13 | 有限会社梅田事務所 | 認知機能の改善作用を有する鶏胸肉由来プラズマローゲン組成物及びこれを含有して成る認知機能の向上及び/又は改善用食品組成物又はサプリメント |
KR20190003570A (ko) * | 2016-05-02 | 2019-01-09 | 우메다 지무쇼 리미티드 | 안전한·안정된 플라스마로겐과 그 제제 및 인지증의 미병 상태의 판정 방법 |
JP6842970B2 (ja) * | 2017-03-30 | 2021-03-17 | 日清ファルマ株式会社 | コエンザイムq10含有製剤 |
JP6518800B1 (ja) * | 2018-02-16 | 2019-05-22 | 株式会社 レオロジー機能食品研究所 | プラズマローゲンを含む機能性素材の製造方法 |
JP6585749B2 (ja) | 2018-02-21 | 2019-10-02 | 丸大食品株式会社 | リン脂質濃縮物製造方法 |
JP6749955B2 (ja) * | 2018-02-21 | 2020-09-02 | 丸大食品株式会社 | 乳化組成物製造方法 |
JP6542408B1 (ja) | 2018-02-21 | 2019-07-10 | 丸大食品株式会社 | リン脂質濃縮物生産方法 |
US20230293415A1 (en) * | 2020-06-30 | 2023-09-21 | Institute Of Rheological Function Of Food Co., Ltd. | Composition for ameliorating skin condition |
KR102650031B1 (ko) * | 2020-12-11 | 2024-03-22 | (주)에이앤바이오 | 반려동물 심장 기능 개선용 조성물 및 이를 포함하는 기능성 식품 |
EP4438610A1 (en) | 2021-11-22 | 2024-10-02 | Institute of Rheological Function of Food Co., Ltd. | Compound, racemate of said compound, salt of said compound or said racemate, composition, anti-inflammatory agent, therapeutic agent for dementia, and therapeutic agent for rett syndrome |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0797323A (ja) * | 1993-05-07 | 1995-04-11 | Suntory Ltd | 鉄吸収促進剤 |
JPH0881371A (ja) * | 1994-09-09 | 1996-03-26 | Suntory Ltd | 造血機能亢進剤 |
JPH11206335A (ja) * | 1998-01-29 | 1999-08-03 | Senmi Extract Kk | 抗アレルギー天然調味料 |
JP2001029042A (ja) * | 1999-07-19 | 2001-02-06 | Nikken Foods Co Ltd | 食用天然カルノシン含有組成物 |
JP4102093B2 (ja) * | 2002-04-02 | 2008-06-18 | 洋 三嶋 | キジ肉抽出物の製造方法 |
US20090068281A1 (en) * | 2005-03-29 | 2009-03-12 | Koji Toyomura | Composition, Functional Food and Pharmaceutical Composition for Improvement in Obesity |
WO2007116987A1 (ja) * | 2006-03-31 | 2007-10-18 | Nippon Meat Packers, Inc. | 学習機能向上効果及び抗不安効果を有する機能性食品及び薬剤 |
JP5010248B2 (ja) * | 2006-11-22 | 2012-08-29 | 焼津水産化学工業株式会社 | アルコール酔い軽減用組成物 |
-
2008
- 2008-09-10 JP JP2008232555A patent/JP5483846B2/ja active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019208392A1 (ja) | 2018-04-27 | 2019-10-31 | 株式会社レオロジー機能食品研究所 | 新規プラズマローゲン誘導体 |
KR20210005190A (ko) | 2018-04-27 | 2021-01-13 | 가부시키가이샤 레오로지 키노쇼쿠힝겐큐죠 | 신규 플라스말로젠 유도체 |
US12060379B2 (en) | 2018-04-27 | 2024-08-13 | Institute of Rheological Functions of Food | Plasmalogen derivatives |
WO2020213132A1 (ja) | 2019-04-18 | 2020-10-22 | 株式会社レオロジー機能食品研究所 | プラズマローゲンを含む機能性素材の製造方法 |
US11491170B2 (en) | 2019-04-18 | 2022-11-08 | Institute of Rheological Functions of Food | Method for manufacturing functional material including plasmalogen |
Also Published As
Publication number | Publication date |
---|---|
JP2010063406A (ja) | 2010-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5483846B2 (ja) | 鳥類ムネ肉から得られる機能性素材及びその製造方法 | |
JP6016363B2 (ja) | 脳神経細胞新生剤 | |
EP2308954B1 (en) | Method for production of highly pure phospholipid, and highly pure sphingomyelin and plasmalogen-type glycerophospholipid produced by the method | |
US8394401B2 (en) | Antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine | |
Yatoo et al. | Effect of fenugreek and black cumin seeds as feed additives on blood biochemical profile and performance of broilers | |
JP6754394B2 (ja) | 食用PLs組成物とこれを含有して成る健常被験者の言語と状況に関連した物忘れがないようにするための食品組成物 | |
JP2019140919A (ja) | プラズマローゲンを含む機能性素材の製造方法 | |
JP2014131961A (ja) | 動物用栄養組成物 | |
WO2010047404A1 (ja) | 常温保存安定化機能性乾燥物またはその粉砕物とその抽出画分の製造方法、およびそれらの用途 | |
JPH1084880A (ja) | 脂質代謝促進作用を有するリン脂質含有組成物 | |
WO2017191838A1 (ja) | 安全・安定なプラズマローゲンとその製剤及び認知症の未病状態の判定方法 | |
JP2006271377A (ja) | 動物肝臓の酵素分解物および該酵素分解物を含有する食品 | |
WO2020213132A1 (ja) | プラズマローゲンを含む機能性素材の製造方法 | |
JP2003267992A (ja) | 抗酸化剤、老化防止剤および/または抗ガン剤 | |
JP5689055B2 (ja) | 鳥皮由来スフィンゴミエリン含有物を有効成分とする抗高血糖及び/又は抗高脂血症剤 | |
CN109153693B (zh) | 安全-稳定的缩醛磷脂和其制剂及认知症的未病状态的判断方法 | |
JP2021138676A (ja) | 機能性複合脂質 | |
JP4115183B2 (ja) | 飼料添加物、それが添加された飼料並びに卵 | |
JP2005289984A (ja) | ハイショウソウを含有する高脂血症改善剤 | |
JP6842093B2 (ja) | 学習記憶能力増強剤 | |
WO2023054477A1 (ja) | アロエ抽出物の製造方法 | |
WO2011083853A1 (ja) | 抗アトピー性皮膚炎剤 | |
JP2021155565A (ja) | エーテル型グリセロリン脂質含有機能性素材の製造方法 | |
JPH1084879A (ja) | 肝臓中性脂肪合成抑制作用を有する粗大豆レシチン分画物 | |
KR20080008794A (ko) | 저분자 굴 액기스를 이용한 지질대사 활성화 식품의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110804 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120423 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120508 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120705 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130305 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130502 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140128 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140218 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5483846 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |